GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 314.61
+3.28 (1.05%)
At close: Sep 17, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 100.19 billion as of September 17, 2026. Its market cap has decreased by -23.71% in one year.
Market Cap
100.19B
Enterprise Value
92.12B
Revenue
67.12B
Ranking
n/a
PE Ratio
9.62
Stock Price
314.61
ChartMarket Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 100.19B, an increase of 2,557.04%. That is a compound annual growth rate of 10.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 100.19B | -19.29% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 89.61B |
| Highnoon Laboratories | 48.22B |
| The Searle Company | 46.15B |
| AGP Limited | 42.06B |
| Citi Pharma | 16.89B |
| Ferozsons Laboratories | 14.36B |
| Macter International | 11.07B |
| Otsuka Pakistan | 4.10B |